Recent Publications
Mark Agulnik, MD
Brockstein B, Lacouture M, Agulnik M.The Role of Inhibitors of the Epidermal Growth Factor in Management of Head and Neck Cancer. J Natl Compr Canc Netw. 2008 Aug;6(7):696-706 PMID: 18691458
Vidal L, Tsao MS, Pond GR, Cohen EE, Cohen RB, ChenEX, Agulnik M, Hotte S, Winquist E, Laurie S, Neil Hayes D, Ho J, Dancey J, Siu LL.Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib. Head Neck. 2009 Mar 23; [Epub ahead of print]. PMID: 19309723
Jessica K. Altman, MD
Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. PMID: 19285282
Charles Bennett, MD, PhD
Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL.Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. 2008 Dec;9(12):1166-72. PMID: 19038763
Simon MA, Dong X, Bennett CL. Partnering to promote equality in cancer care. Soc Work Public Health. 2009 Jul-Aug;24(4):355-9. PMID: 19517300
Simon MA, Dong X, Nonzee N, Bennett CL.Heeding Our Words: Complexities of Research Among Low-Literacy
Populations. J Clin Oncol. 2009 Mar 23; [Epub ahead of print]. PMID: 19307497
Populations. J Clin Oncol. 2009 Mar 23; [Epub ahead of print]. PMID: 19307497
Al B. Benson III, MD
Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, Benson A 3rd, Omary RA, Salem R. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer. 2008 Aug 29; [Epub ahead of print] PMID: 18759346
Berger AC, Garcia M Jr, Hoffman JP, Regine WF, Abrams RA, Safran H, Konski A, Benson AB 3rd, Macdonald J, Willett CG. Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With
Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704. J Clin Oncol. 2008 Nov 24; PMID: 19029412
Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704. J Clin Oncol. 2008 Nov 24; PMID: 19029412
Benson AB. Advanced gastric cancer: an update and future directions. Gastrointest Cancer Res. 2008 Jul;2(4 Suppl):S47-53. Gastrointest Cancer Res. 2008 Jul;2(4 Suppl):S47-53.
Benson AB, Moore M. Accomplishments in 2007 in the management of localized pancreatic cancer. Gastrointest Cancer Res. 2008 May;2(3 Suppl):S32-6. PMID: 19352466
John D. Crispino, PhD
Malinge, S, Izraeli, S, and Crispino JD. (2009) Insights into the manifestations, outcomes and mechanisms of
leukemogenesis in Down syndrome. Blood 113:2619-2628.
leukemogenesis in Down syndrome. Blood 113:2619-2628.
Wen Q, Leung C, Huang Z, Small S, Lakku Reddi A, Licht JD, Crispino JD. Survivin is not required for the
endomitotic cell cycle of megakaryocytes. Blood. 2009 Apr 1; [Epub ahead of print] PMID: 19339696
endomitotic cell cycle of megakaryocytes. Blood. 2009 Apr 1; [Epub ahead of print] PMID: 19339696
Stankiewicz, MJ, and Crispino JD. (2009) ETS2 and ERG promote megakaryopoiesis and synergize with loss of
GATA-1 to immortalize hematopoietic progenitor cells. Blood 113:3337-3347.
GATA-1 to immortalize hematopoietic progenitor cells. Blood 113:3337-3347.
Abdel-Wahab, O., Mullally, A, Hedvat, C, Garcia-Maero, G, Patel, J, Malinge S, Yao, J, Kilipavaara, O, Wadleigh, M, Bhat, R, Huberman, K, Thomas, S, Dolgalev, I, Heguy, A, Paietta, E, Le Beau, M, Beran, M, Tallman, M, Kantarjian, H, Ebert, B, Gilliland, DG, Crispino, JD, and Levine, R. (2009) Genetic characteristics of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood, in press. Pre-published on line May 6, 2009. DOI 10.1182/blood-2009-03-210039.
Chou, St, Khandros, E, Bailey, C, Nichols, KE, Vakoc, C, Yao, Y, Huang, Z, Crispino, JD, Blobel, GA, and Weiss, MJ. Graded repression of PU1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood, in press. Pre-published on line June 2, 2009. DOI 10.1182/blood-2009-03-207944.
Olga Frankfurt, MD
Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic
leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. PMID: 19285282
leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. PMID: 19285282
William J. Gradishar, MD
Desai NP, Trieu V, Hwang LY, Wu R, Soon-Shiong P, Gradishar WJ. Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status. Anticancer Drugs. 2008 Oct;19(9):899-909. PMID: 18766004
David Green, MD, PhD
Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE, Green DM, Fritsch MK, Perlman EJ.Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res. 2009 Feb 10. [Epub ahead of print]. PMID: 19208794
Virginia Kaklamani, MD
Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, Baron JA, Ahsan H, Mantzoros C, Pasche B.
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008 Oct 1;300(13):1523-31. PMID: 18827209
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008 Oct 1;300(13):1523-31. PMID: 18827209
Timothy Kuzel, MD
Gerami P, Guitart J, Rosen S, Kuzel TM. Interleukins in the treatment of mycosis fungoides. G Ital Dermatol Venereol. 2008 Feb;143(1):55-8. PMID: 18833051
Rao D, Butt Z, Rosenbloom S, Robinson D Jr, Von Roenn J, Kuzel TM, Cella D. A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). J Pain Symptom Manage. 2009 Apr 6;. [Epub ahead of print] PMID: 19356897
Hau Kwaan, MD
McMahon B, Kwaan HC. The plasminogen activator system and cancer. Pathophysiol Haemost Thromb. 2008;36(3-4):184-94. Epub 2009 Jan 27.
Ruch J, McMahon B, Ramsey G, Kwaan HC. Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol. 2008 Nov 10;84(2):120-122. [Epub ahead of print]. PMID: 19097173
McMahon B, Kwaan HC. The plasminogen activator system and cancer. Pathophysiol Haemost Thromb. 2008;36(3-4):184-94. Epub 2009 Jan 27.
Ruch J, McMahon B, Ramsey G, Kwaan HC. Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol. 2008 Nov 10;84(2):120-122. [Epub ahead of print]. PMID: 19097173
Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. PMID: 19285282
Jonathan Licht, MD
Wen Q, Leung C, Huang Z, Small S, Lakku Reddi A, Licht JD, Crispino JD. Survivin is not required for the
endomitotic cell cycle of megakaryocytes. Blood. 2009 Apr 1; [Epub ahead of print] PMID: 19339696
endomitotic cell cycle of megakaryocytes. Blood. 2009 Apr 1; [Epub ahead of print] PMID: 19339696
Benson AB. Advanced gastric cancer: an update and future directions. Gastrointest Cancer Res. 2008 Jul;2(4 Suppl):S47-53. Gastrointest Cancer Res. 2008 Jul;2(4 Suppl):S47-53.
Brandon McMahon, MD
McMahon B, Kwaan HC. The plasminogen activator system and cancer. Pathophysiol Haemost Thromb. 2008;36(3-4):184-94. Epub 2009 Jan 27.
Ruch J, McMahon B, Ramsey G, Kwaan HC. Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol. 2008 Nov 10;84(2):120-122. [Epub ahead of print]. PMID: 19097173
McMahon B, Kwaan HC. The plasminogen activator system and cancer. Pathophysiol Haemost Thromb. 2008;36(3-4):184-94. Epub 2009 Jan 27.
Ruch J, McMahon B, Ramsey G, Kwaan HC. Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin
developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol. 2008 Nov 10;84(2):120-122. [Epub ahead of print]. PMID: 19097173
developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol. 2008 Nov 10;84(2):120-122. [Epub ahead of print]. PMID: 19097173
Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. PMID: 19285282
Alexander C Minella, MD
Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney B, Bernstein ID, Roberts JM, and Clurman BE. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes and Development 2008; 22: 1677-89.
Mary F. Mulcahy, MD
Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, Benson A 3rd, Omary RA, Salem R. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer. 2008 Aug 29; [Epub ahead of print] PMID: 18759346
Ibrahim SM, Nikolaidis P, Miller FH, Lewandowski RJ, Ryu RK, Sato KT, Senthilnathan S, Riaz A, Kulik L, Mulcahy MF, Omary RA, Salem R. Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging. 2008 Sep 7; [Epub ahead of print] PMID: 18777189
Hidayatullah G. Munshi, MD
Moss NM, Liu Y, Johnson JJ, Debiase P, Jones J, Hudson LG, Munshi HG, Stack MS. Epidermal Growth Factor Receptor-Mediated Membrane Type 1 Matrix Metalloproteinase Endocytosis Regulates the Transition between Invasive versus Expansive Growth of Ovarian Carcinoma Cells in Three-Dimensional Collagen. Mol Cancer Res. 2009 Jun 9. [Epub ahead of print] PMID: 19509114
Moss NM Phd, Wu YI Phd, Liu Y Md, Munshi HG Md, Stack MS Phd. J Biol. Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices. Chem. 2009 May 19. [Epub ahead of print] PMID: 19458085
Jayesh Mehta, MD
Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL.Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. 2008 Dec;9(12):1166-72. PMID: 19038763
Jyoti Patel, MD
Abdel-Wahab, O., Mullally, A, Hedvat, C, Garcia-Maero, G, Patel, J, Malinge S, Yao, J, Kilipavaara, O, Wadleigh, M, Bhat, R, Huberman, K, Thomas, S, Dolgalev, I, Heguy, A, Paietta, E, Le Beau, M, Beran, M, Tallman, M, Kantarjian, H, Ebert, B, Gilliland, DG, Crispino, JD, and Levine, R. (2009) Genetic characteristics of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood, in press. Pre-published on line May 6, 2009. DOI 10.1182/blood-2009-03-210039.
Leonidas C. Platanias, MD
Kroczynska B, Kaur S, Katsoulidis E, Majchrzak-Kita B, Sassano A, Kozma SC, Fish EN, Platanias LC.
Interferon-dependent engagement of eukaryotic initiation factor 4B (eIF4B) via S6K- and RSK-mediated signals.
Interferon-dependent engagement of eukaryotic initiation factor 4B (eIF4B) via S6K- and RSK-mediated signals.
Stephen Rosen, MD
Gerami P, Guitart J, Rosen S, Kuzel TM. Interleukins in the treatment of mycosis fungoides. G Ital Dermatol Venereol. 2008 Feb;143(1):55-8. PMID: 18833051
Seema Singhal, MD
Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL.Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. 2008 Dec;9(12):1166-72. PMID: 19038763
Martin S. Tallman, MD
Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic
leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. PMID: 19285282
leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. PMID: 19285282
Abdel-Wahab, O., Mullally, A, Hedvat, C, Garcia-Maero, G, Patel, J, Malinge S, Yao, J, Kilipavaara, O, Wadleigh, M, Bhat, R, Huberman, K, Thomas, S, Dolgalev, I, Heguy, A, Paietta, E, Le Beau, M, Beran, M, Tallman, M, Kantarjian, H, Ebert, B, Gilliland, DG, Crispino, JD, and Levine, R. (2009) Genetic characteristics of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood, in press. Pre-published on line May 6, 2009. DOI 10.1182/blood-2009-03-210039.
Jamie Von Roenn, MD
Rao D, Butt Z, Rosenbloom S, Robinson D Jr, Von Roenn J, Kuzel TM, Cella D. A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). J Pain Symptom Manage. 2009 Apr 6;. [Epub ahead of print] PMID: 19356897
Sigmund Weitzman, MD
Weitzman SA.Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial--invited commentary. Arch Intern Med. 2008 Nov 24;168(21):2332. PMID: 19029497
- DIVISIONS
- Allergy-Immunology
- Cardiology
- Endocrinology
- Gastroenterology
- General Internal Medicine
- Geriatric Medicine
- Hematology-Oncology
- Hepatology
- Hospital Medicine
- Immunotherapy
- Infectious Diseases
- Nephrology-Hypertension
- Pulmonary And Critical Care
- Rheumatology
- Sports Medicine
- RESIDENCY
- STUDENTS
- RESEARCH
